Pharmafile Logo

Debra Ainge

- PMLiVE

Roche, AbbVie hit by clinical hold for Venclexta in myeloma

Safety concerns could hit blockbuster expectations

Bristol Myers Squibb logo

BMS defends Celgene buyout ahead of shareholder vote

BMS battles for hearts and minds before shareholder vote

- PMLiVE

Is May’s Brexit deal sinking after Speaker’s procedural torpedo?

Life sciences firms must keep planning for no-deal - for now

- PMLiVE

Apple Watch shows promise in heart study, but doctors sceptical

Study important for Apple's ambitions in healthcare

- PMLiVE

New faces at 11 London, ramarketing and MSL

Latest movers in healthcare comms

- PMLiVE

Genomics integration: can the NHS rise to the challenge?

Experts gather to discuss the UK’s genomic landscape

- PMLiVE

Sanofi gets cardio outcomes claim for Praluent in EU

Data stronger than rival's, could spark a fight back

- PMLiVE

NICE wants to stop saying ‘no’ – but needs pharma’s co-operation

Suggests Orkambi row has undermined confidence in NICE process

Three questions that should anchor your brand strategy

Ensuring the organisation is focused on pursuing the most attractive commercial opportunities

- PMLiVE

Allergy Tx hit hard as birch pollen product stumbles

Shares in the company went into a steep decline this morning

- PMLiVE

Blood disorder specialists Imara raises $63m

Arix Biosciences claims a 10% stake in the biotech

- PMLiVE

Bringing life to precision medicine

Harnessing the power of patient-derived organoids

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links